Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YKP3089 in Treatment Resistant Partial Onset Seizures
NCT01397968Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Jul 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of cenobamate in partial epilepsy, sponsored by SK Life Science, Inc.. Started Jul 2011; status: completed.
02
Drugs
cenobamate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT01397968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01397968.